Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Recombinant oncolytic adenovirus for human melanoma

Recombinant oncolytic adenovirus for human melanoma

US Patent 7048920 · Granted May 23, 2006

Estimated economic value: $2,967,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

PD-1 antibodies2021
PD-1 antibodies2020
Adenovirus vectors containing cell status-specific response elements and methods2011
Adenovirus vectors containing cell status-specific response elements and methods2011
Pan cancer oncolytic vectors and methods of use thereof2010
Adenovirus vectors containing cell status-specific response elements and methods2009
Hepatocellular carcinoma specific promoter and uses thereof2009
Pan cancer oncolytic vectors and methods of use thereof2009
Cell-specific adenovirus vector comprising EBV-specific promoter2008
Metastatic colon cancer specific promoter and uses thereof2008
Metastatic colon cancer specific promoter and uses thereof2008
Adenovirus vectors specific for cells expressing androgen receptor and methods o2008